Clinical Trial Update: Dapagliflozin in Active Lupus Nephritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating dapagliflozin for active lupus nephritis. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Lupus Nephritis (LN) | Phase 4 | Status: NOT_YET_RECRUITING